Molecular Biology Reports

, Volume 39, Issue 5, pp 5659–5667 | Cite as

Comparative proteomics analysis of serum proteins in ulcerative colitis patients

  • Nan Li
  • Xueming Wang
  • Yuefan Zhang
  • Junshan Zhai
  • Tuo Zhang
  • Kaihua Wei


In the present study, we investigated the differentially expressed proteins associated with ulcerative colitis (UC) using proteomic methods. Two-dimensional electrophoresis (2-DE) technology was performed to separate the total proteins of ulcerative tissues from those of the normal tissues of UC patients. PDQuest software was applied to analyze the obtained 2-DE images. Candidate protein spots between the two groups were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and bioinformatics analysis. The well resolution and reproducible 2-DE patterns of UC and normal tissues were established. Of the 12 differentially expressed proteins, 9 were successfully identified, of which 6 proteins were up-regulated including apolipoprotein C-III, haptoglobin, receptor tyrosine kinase, aldehyde reductase, pericentriolar material 1, and heat shock factor protein 2, and 3 were down-regulated including keratin, filamin A-interacting protein 1, and tropomyosin 3. These identified proteins were related to hormonal modulation, immune response, oxidative stress, and signal conduction. The 2-DE protein expression profile of the UC tissues displays an obvious difference from that of the normal controls. Various proteins may be involved in the occurrence of UC.


Ulcerative colitis Two dimensional electrophoresis Mass spectrogram Serum 



This work was supported by the grants from the National Key Lab Proteomics, China (No. 2009-J-0801).


  1. 1.
    Braus NA, Elliott DE (2009) Advances in the pathogensis and treatment of IBD. Clin Immunol 132:1–9PubMedCrossRefGoogle Scholar
  2. 2.
    Venter JC, Adams MD, Myers EW et al (2001) The sequence of the human genome. Science 291:1304–1351PubMedCrossRefGoogle Scholar
  3. 3.
    Pandey A, Mann M (2000) Proteomics to study genes and genomes. Nature 405:837–846PubMedCrossRefGoogle Scholar
  4. 4.
    Baumgart DC, Sandborn WJ (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369:1641–1657PubMedCrossRefGoogle Scholar
  5. 5.
    Degner D, Bleich S, Riegel A, Sprung R, Poser W, Rüther E (2000) Follow-up study after enteral manganese poisoning: clinical, laboratory and neuroradiological findings. Nervenarzt 71:416–419PubMedCrossRefGoogle Scholar
  6. 6.
    Zeindl-Eberhart E, Klugbauer S, Dimitrijevic N, Jungblut PR, Lamer S, Rabes HM (2001) Proteome analysis of rat hepatomas: careinogen-dependent tumor-associated protein variants. Electrophoresis 22:3009–3018PubMedCrossRefGoogle Scholar
  7. 7.
    Hsieh SY, Shih TC, Yeh CY, Lin CJ, Chou YY, Lee YS (2006) Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics 6:5322–5331PubMedCrossRefGoogle Scholar
  8. 8.
    Stupka E (2002) Large-scale open bioinformatics date resources. Curr Opin Mol Ther 4:265–274PubMedGoogle Scholar
  9. 9.
    Song HY, Liu YK, Feng JT, Cui JF, Dai Z, Zhang LJ, Feng JX, Shen HL, Tang ZY (2006) Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol 132:92–98PubMedCrossRefGoogle Scholar
  10. 10.
    Hoffman SA, Joo WA, Echan LA, Speicher DW (2007) Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma. J Chromatogr B Anal Technol Biomed Life Sci 849:43–52CrossRefGoogle Scholar
  11. 11.
    Anderson NL, Anderson NG (2002) The hunman plasma proteome: history, haracter, and diagnostic prospects. Mol Cell Proteomics 1:845–867PubMedCrossRefGoogle Scholar
  12. 12.
    Rabilloud T (2002) Two-dimensional gel electrophoresis in proteomics: old fashioned, but it still climbs up the mountains. Proteomics 2:3–10PubMedCrossRefGoogle Scholar
  13. 13.
    Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2000. CA Cancer J Clin 55:74–108PubMedCrossRefGoogle Scholar
  14. 14.
    Ramagli LS (1999) Quantifying protein in 2-D PAGE solubilization buffers. Methods Mol Biol 112:99–103PubMedGoogle Scholar
  15. 15.
    Bjorhall K, Miliotis T, Davidsson P (2005) Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5:307–317PubMedCrossRefGoogle Scholar
  16. 16.
    Feng JT, Liu YK, Song HY, Dai Z, Qin LX, Almofti MR, Fang CY, Lu HJ, Yang PY, Tang ZY (2005) Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 5:4581–4588PubMedCrossRefGoogle Scholar
  17. 17.
    Huang HL, Stasyk T, Morandell S, Dieplinger H, Falkensammer G, Griesmacher A, Mogg M, Schreiber M, Feuerstein I, Huck CW, Stecher G, Bonn GK, Huber LA (2006) A Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis 27:1641–1650PubMedCrossRefGoogle Scholar
  18. 18.
    Nakai A, Tanabe M, Kawazoe Y, Inazawa J, Morimoto RI, Nagata K (1997) HSF4, a new member of the human heat shock factor family which lacks properties of a transcriptional activator. Mol Cell Biol 17:469–481PubMedGoogle Scholar
  19. 19.
    Arya R, Mallik M, Lakhotia SC (2007) Heat shock genes-integrating cell survival and death. J Biosci 32:595–610PubMedCrossRefGoogle Scholar
  20. 20.
    Morimoto RI (1998) Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 12:3788–3796PubMedCrossRefGoogle Scholar
  21. 21.
    Knowlton AA (2006) NFkappaB, heat shock proteins, HSF-1 and inflammation. Cardiovasc Res 69:7–8PubMedCrossRefGoogle Scholar
  22. 22.
    Malago JJ, Koninkx JF, van Dijk JE (2002) The heat shock response and cytoprotection of the intestinal epithelium. Cell Stress Chaperones 7:191–199PubMedCrossRefGoogle Scholar
  23. 23.
    Meuwis MA, Fillet M, Geurts P, de Seny D, Lutteri L, Chapelle JP, Bours V, Wehenkel L, Belaiche J, Malaise M, Louis E, Merville MP (2007) Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochem Pharmacol 73:1422–1433PubMedCrossRefGoogle Scholar
  24. 24.
    Kawakami A, Aikawa M, Libby P, Alcaide P, Luscinskas FW, Sacks FM (2006) Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Circulation 113:691–700PubMedCrossRefGoogle Scholar
  25. 25.
    Seth R, Raymond FD, Makgoba MW (1991) Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 338:83–84PubMedCrossRefGoogle Scholar
  26. 26.
    Vainer B, Nielsen OH (2003) Correlation between circulating soluble ICAM-1 and prednisolone-induced amelioration of ulcerative colitis. Scand J Gastroenterol 38:283–287PubMedGoogle Scholar
  27. 27.
    Kawakami A, Aikawa M, Nitta N, Yoshida M, Libby P, Sacks FM (2007) Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein-and protein kinase C alpha-mediated nuclear factor-kappaB activation. Arteroscler Thromb Vasc Bio1 27:219–225CrossRefGoogle Scholar
  28. 28.
    Broedl UC, Schachinger V, Lingenhel A, Lehrke M, Stark R, Seibold F, Göke B, Kronenberg F, Parhofer KG, Konrad-Zerna A (2007) Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease. Inflamm Bowel Dis 13:391–397PubMedCrossRefGoogle Scholar
  29. 29.
    Tammali R, Ramana KV, Singhal SS, Awasthi S, Srivastava SK (2006) Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res 66:9705–9713Google Scholar
  30. 30.
    Spaulding HL, Saijo F, Turnage RH, Alexander JS, Aw TY, Kalogeris TJ (2006) Apolipoprotein A-IV attenuates oxidant-induced apoptosis in mitotic competent, undifferentiated cells by modulating intracellular glutathione rodox balance. Am J Physiol Cell Physiol 290:C95–C103PubMedCrossRefGoogle Scholar
  31. 31.
    Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103:211–225PubMedCrossRefGoogle Scholar
  32. 32.
    Frey MR, Edelblum KL, Mullane MT, Liang D, Polk DB (2009) The ErbB4 growth factor receptor is required for colon epithelial cell survival in the presence of TNF. Gastroenterology 136:217–226PubMedCrossRefGoogle Scholar
  33. 33.
    Sladek NE, Kollander R, Sreerama L (2002) Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer Chemother Pharmacol 49:309–321PubMedCrossRefGoogle Scholar
  34. 34.
    Chen B, Wen Y, Polan ML (2004) Elastolytic activity in women with stress urinary incontinence and pelvic organ prolapsed. Neurourol Urodyn 23:119–126PubMedCrossRefGoogle Scholar
  35. 35.
    Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L, Pickell K, Aguilar J, Lazetic S, Smith-Berdan S, Clarke MF, Hoey T, Lewicki J, Gurney AL (2008) Colorectal cancer stem cells are enriched in xengeneic tumors following chemotherapy. PLoS One 3:e2428PubMedCrossRefGoogle Scholar
  36. 36.
    Tammali R, Ramana KV, Srivastava SK (2007) Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells. Cancer Lett 252:299–306PubMedCrossRefGoogle Scholar
  37. 37.
    Foth BJ, Goedecke MC, Soldati D (2006) New insights into myosin evolution and classification. Proc Natl Acad Sci USA 103:3681–3686PubMedCrossRefGoogle Scholar
  38. 38.
    Bornens M (2002) Centrosome composition and microtubule anchoring mechanisms. Curr Opin Cell Biol 14:25–34PubMedCrossRefGoogle Scholar
  39. 39.
    Drewes PG, Yanagisawa H, Starcher B, Hornstra I, Csiszar K, Marinis SI, Keller P, Word RA (2007) Pelvic organ prolapse in fibulin-5 knockout mice: pregnancy-induced changes in elastic fiber homeostasis in mouse vagina. Am J Pathol 17:5578–5589Google Scholar
  40. 40.
    Skorupski P, Miotla P, Jankiewicz K, Rechberger T (2007) Polymorphism of the gene encoding alpha-1 chain of collagen type 1 and a risk of pelvic organ prolapse-a preliminary study. Ginekol Pol 78:852–855PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Nan Li
    • 1
  • Xueming Wang
    • 1
    • 2
  • Yuefan Zhang
    • 1
  • Junshan Zhai
    • 1
  • Tuo Zhang
    • 1
  • Kaihua Wei
    • 1
  1. 1.Department of Gastenerology309 Hospital, PLABeijingChina
  2. 2.Department of Pharmacy309 Hospital, PLABeijingChina

Personalised recommendations